Melanie E Royce

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis
    Melanie E Royce
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:12-9. 2004
  2. ncbi A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum
    Melanie E Royce
    The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Invest New Drugs 22:53-61. 2004
  3. pmc Modeling the effect of tumor size in early breast cancer
    Claire Verschraegen
    Division of Hematology Oncology, Cancer Research and Treatment Center, University of New Mexico, Albuquerque, New Mexico 87131, USA
    Ann Surg 241:309-18. 2005
  4. ncbi Idiopathic granulomatous lobular mastitis masquerading as a breast abscess and breast carcinoma
    Dalice A Marriott
    University of New Mexico Cancer Research and Treatment Center, Department of Internal Medicine, Albuquerque, New Mexico 87131 0001, USA
    Am J Clin Oncol 30:564-5. 2007
  5. doi Breast disease: benign and malignant
    Angela L W Meisner
    Population Science, Cancer Health Disparities and Cancer Control, Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USA
    Med Clin North Am 92:1115-41, x. 2008

Collaborators

Detail Information

Publications5

  1. ncbi STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis
    Melanie E Royce
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:12-9. 2004
    ..The authors also explored whether STK15 was a prognostic factor for breast carcinoma by comparing the level of STK15 gene expression with clinical parameters that are known prognostic factors for the disease...
  2. ncbi A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for five days every three weeks to patients with metastatic adenocarcinoma of the colon or rectum
    Melanie E Royce
    The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Invest New Drugs 22:53-61. 2004
    ..To evaluate the antitumor activity, toxicities, and pharmacokinetics (PK) of DX-8951f administered as a 30-min infusion daily for 5 days every 3 weeks in patients with fluorouracil-resistant metastatic colorectal carcinoma...
  3. pmc Modeling the effect of tumor size in early breast cancer
    Claire Verschraegen
    Division of Hematology Oncology, Cancer Research and Treatment Center, University of New Mexico, Albuquerque, New Mexico 87131, USA
    Ann Surg 241:309-18. 2005
    ..The purpose of this study was to determine the type of relationship between tumor size and mortality in early breast carcinoma...
  4. ncbi Idiopathic granulomatous lobular mastitis masquerading as a breast abscess and breast carcinoma
    Dalice A Marriott
    University of New Mexico Cancer Research and Treatment Center, Department of Internal Medicine, Albuquerque, New Mexico 87131 0001, USA
    Am J Clin Oncol 30:564-5. 2007
  5. doi Breast disease: benign and malignant
    Angela L W Meisner
    Population Science, Cancer Health Disparities and Cancer Control, Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USA
    Med Clin North Am 92:1115-41, x. 2008
    ..In all women aged 40 and over presenting with abnormalities of the breast, a primary breast cancer should be ruled out because it is the leading cancer among women in developed countries...